Inovio Pharmaceuticals
INO
$12.01
Share price
3.62%
Change (1 day)
1,480.26%
Change (1 year)
Categories
EPS for Inovio Pharmaceuticals (INO)
EPS in 2023 (TTM): -$0.65
According to Inovio Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$0.65. In 2022 the company made an earnings per share (EPS) of -$1.18 an increase over its 2021 EPS that were of -$1.45.
EPS history for Inovio Pharmaceuticals from 2001 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$0.65 | -44.92% |
| 2022 | -$1.18 | -18.62% |
| 2021 | -$1.45 | 34.26% |
| 2020 | -$1.08 | -10.74% |
| 2019 | -$1.21 | 15.24% |
| 2018 | -$1.05 | -0.94% |
| 2017 | -$1.06 | 4.95% |
| 2016 | -$1.01 | 129.55% |
| 2015 | -$0.44 | -29.03% |
| 2014 | -$0.62 | -55.71% |
| 2013 | -$1.40 | 141.38% |
| 2012 | -$0.58 | 20.83% |
| 2011 | -$0.48 | -25% |
| 2010 | -$0.64 | -56.76% |
| 2009 | -$1.48 | 23.33% |
| 2008 | -$1.20 | 11.11% |
| 2007 | -$1.08 | -41.3% |
| 2006 | -$1.84 | -67.14% |
| 2005 | -$5.60 | 115.38% |
| 2004 | -$2.60 | -62.21% |
| 2003 | -$6.88 | 186.67% |
| 2002 | -$2.40 | -0% |
| 2001 | -$2.40 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $14.09 | -2,266.97% | 🇺🇸 USA |
 Novartis NVS | $3.74 | -675.38% | 🇨🇭 Switzerland |
 Pfizer PFE | $1.86 | -386.15% | 🇺🇸 USA |
 Gilead Sciences GILD | $4.39 | -775.38% | 🇺🇸 USA |
 Merck MRK | $1.82 | -380.26% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $3.50 | -638.57% | 🇬🇧 UK |
 Arrowhead Pharmaceuticals
ARWR | -$1.70 | 161.54% | 🇺🇸 USA |